MiMARK
Barcelona
About MiMARK
MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $7.5M
- Funding stage: Seed
- Last round: Seed (Sep 2025)
- Website: mimark.es
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/mimark-28078 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.